Company Search:
Advanced Search
Sponsored Links
AstraZeneca PLC - ADR Company Snapshot
AstraZeneca PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other companies in this sector in UNITED STATES : Eli Lilly and Company (2019 sales of $22.32 billion of which 100% was Human Pharmaceuticals products), Takeda Pharmaceutical Company Limited ($18.90 billion of which 97% was Pharmaceutical Business), and Bristol-Myers Squibb Company ($26.15 billion of which 30% was Prioritized Brands-Eliquis).

Sales Analysis. During the year ended December of 2019, sales at AstraZeneca PLC were $24.38 billion. This is an increase of 10.4% versus 2018, when the company's sales were $22.09 billion. The sales level in 2019 was fairly close to the level five years ago: in 2014, AstraZeneca PLC had sales of $26.10 billion.
  Stock Performance Chart for AstraZeneca PLC - ADR
  Stock Data: Recent Stock Performance:
  Current Price (11/27/2020): 52.61
(Figures in U.S. Dollars)
1 Week -4.9%   13 Weeks 4.9%  
4 Weeks -5.5%   52 Weeks 8.5%  
AstraZeneca PLC - ADR Key Data:
  Ticker: AZN Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 24,384,026,713
(Year Ending Jan 2020).
Employees: 70,600
  Currency: U.S. Dollars Market Cap: 138,079,814,266
  Fiscal Yr Ends: December Shares Outstanding: 2,624,592,554
  Share Type: Ordinary Closely Held Shares: 111,567,220
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.